Clinical Trial Update: TOPIK Study: A Study to Report Progressive Multifocal Leukoencephalopathy and Other Serious Opportunistic Infections in Natalizumab Treated Participants

View source ↗

Summary

This document summarizes the TOPIK study update, a completed trial assessing cases of progressive multifocal leukoencephalopathy and other serious opportunistic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Tysabri (Natalizumab)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Status: COMPLETED